Publications Buprenorphine for Children and Adolescents with Sickle Cell Disease: A Scoping Review; Mar 28, 2026; pubmed:41897100. View Buprenorphine for Children and Adolescents with Sickle Cell Disease: A Scoping Review on PubMed Understanding stroke risk phenotypes in pediatric patients with sickle cell disease and concurrent moyamoya arteriopathy: insights from 61 cases at a single institution; Mar 13, 2026; pubmed:41825074. View Understanding stroke risk phenotypes in pediatric patients with sickle cell disease and concurrent moyamoya arteriopathy: insights from 61 cases at a single institution on PubMed Increasing ketamine administration in children's hospitals for youth with sickle cell disease; Dec 3, 2025; pubmed:41337693. View Increasing ketamine administration in children's hospitals for youth with sickle cell disease on PubMed Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis; Oct 14, 2025; pubmed:41084215. View Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis on PubMed A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs; Sep 16, 2025; pubmed:40957551. View A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs on PubMed Retinal Imaging Biomarkers and Correlation to Systemic Disease Activity in Pediatric Sickle Cell Disease; Jun 3, 2025; pubmed:40458663. View Retinal Imaging Biomarkers and Correlation to Systemic Disease Activity in Pediatric Sickle Cell Disease on PubMed Genetic Modifiers Associated with Vaso-Occlusive Crises and Acute Pain Phenomena in Sickle Cell Disease: A Scoping Review; May 14, 2025; pubmed:40362693. View Genetic Modifiers Associated with Vaso-Occlusive Crises and Acute Pain Phenomena in Sickle Cell Disease: A Scoping Review on PubMed Is the early use of ketamine effective as an opioid sparing adjunct for treating pain in sickle cell disease patients?; May 11, 2025; pubmed:40350388. View Is the early use of ketamine effective as an opioid sparing adjunct for treating pain in sickle cell disease patients? on PubMed Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review; Jun 27, 2024; pubmed:38928024. View Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review on PubMed Closing the Equity Gap: Early Intervention in Sickle Cell Disease; Jun 5, 2024; pubmed:38836305. View Closing the Equity Gap: Early Intervention in Sickle Cell Disease on PubMed Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project; May 29, 2024; pubmed:38809385. View Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project on PubMed The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain; May 1, 2024; pubmed:38691085. View The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain on PubMed Reply to: Comment on: Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease; Oct 25, 2023; pubmed:37877853. View Reply to: Comment on: Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease on PubMed Further evidence supporting the global use of hydroxyurea; Oct 10, 2023; pubmed:37815815. View Further evidence supporting the global use of hydroxyurea on PubMed Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling; Sep 20, 2023; pubmed:37730674. View Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling on PubMed Increasing COVID-19 Vaccination Rates for Children With Sickle Cell Disease; Sep 14, 2023; pubmed:37706252. View Increasing COVID-19 Vaccination Rates for Children With Sickle Cell Disease on PubMed F-erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease; Aug 16, 2023; pubmed:37584425. View F-erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease on PubMed Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease; Mar 2, 2023; pubmed:36861789. View Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease on PubMed Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease?; Feb 6, 2023; pubmed:36746630. View Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease? on PubMed Diversity, equity, and inclusion: Moving from ambition to action; Jan 18, 2023; pubmed:36651689. View Diversity, equity, and inclusion: Moving from ambition to action on PubMed Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study; Jan 14, 2023; pubmed:36641004. View Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study on PubMed Does fetal hemoglobin inhibit the malarial parasite Plasmodium falciparum?; Jul 14, 2022; pubmed:35834276. View Does fetal hemoglobin inhibit the malarial parasite Plasmodium falciparum? on PubMed Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries; Mar 10, 2022; pubmed:35264367. View Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries on PubMed A seat at the table: A perspective on participation of Black individuals in clinical trials; Feb 23, 2022; pubmed:35195931. View A seat at the table: A perspective on participation of Black individuals in clinical trials on PubMed Operational Effect of COVID-19 on Surgical Care at a Tertiary Pediatric Hospital; Jan 27, 2022; pubmed:35084769. View Operational Effect of COVID-19 on Surgical Care at a Tertiary Pediatric Hospital on PubMed A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease; Mar 31, 2021; pubmed:33788404. View A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease on PubMed Autoimmune hemolytic anemia complicated by parvovirus infection; Feb 25, 2021; pubmed:33630052. View Autoimmune hemolytic anemia complicated by parvovirus infection on PubMed End the pain: Start with antiracism; Oct 21, 2020; pubmed:33085798. View End the pain: Start with antiracism on PubMed Association of Blood Type With Postsurgical Mucosal Bleeding in Pediatric Patients Undergoing Tonsillectomy With or Without Adenoidectomy; Apr 2, 2020; pubmed:32232448. View Association of Blood Type With Postsurgical Mucosal Bleeding in Pediatric Patients Undergoing Tonsillectomy With or Without Adenoidectomy on PubMed Knowledge of Blood Group Decreases von Willebrand Factor Panel Testing in Children; Nov 15, 2019; pubmed:31723732. View Knowledge of Blood Group Decreases von Willebrand Factor Panel Testing in Children on PubMed Fetal hemoglobin does not inhibit Plasmodium falciparum growth; Jul 18, 2019; pubmed:31311778. View Fetal hemoglobin does not inhibit <em>Plasmodium falciparum</em> growth on PubMed Erythrocyte ion content and dehydration modulate maximal Gardos channel activity in KCNN4 V282M/+ hereditary xerocytosis red cells; May 16, 2019; pubmed:31091145. View Erythrocyte ion content and dehydration modulate maximal Gardos channel activity in KCNN4 V282M/+ hereditary xerocytosis red cells on PubMed Resistance to Plasmodium falciparum in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition; Jun 28, 2018; pubmed:29946035. View Resistance to <em>Plasmodium falciparum</em> in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition on PubMed Pediatric sialoblastoma: Evaluation and management; Jul 3, 2016; pubmed:27368441. View Pediatric sialoblastoma: Evaluation and management on PubMed Diagnosis of iron-deficient states; Aug 21, 2015; pubmed:26292073. View Diagnosis of iron-deficient states on PubMed An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?; Jul 22, 2015; pubmed:26193998. View An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome? on PubMed The utility of the DDAVP challenge test in children with low von Willebrand factor; Mar 4, 2015; pubmed:25733073. View The utility of the DDAVP challenge test in children with low von Willebrand factor on PubMed A diagnostic role for dense cells in sickle cell disease; Sep 24, 2014; pubmed:25246595. View A diagnostic role for dense cells in sickle cell disease on PubMed Hereditary xerocytosis revisited; Jul 22, 2014; pubmed:25044010. View Hereditary xerocytosis revisited on PubMed Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers; Jan 3, 2014; pubmed:24382691. View Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers on PubMed Building partnerships to target sickle cell anemia in Africa; Oct 15, 2013; pubmed:24123084. View Building partnerships to target sickle cell anemia in Africa on PubMed Haiti: how visiting educators can help the most; Feb 28, 2013; pubmed:23442429. View Haiti: how visiting educators can help the most on PubMed Show More Publications Show Fewer Publications